Lee Ainslie profile

Lee Ainslie | Maverick Capital Ltd

Fund Stats for Q2 2015Lee Ainslie is the managing partner of Maverick Capital Ltd. The 13F filing for 2015 Q2 included $6.55B in managed 13F securities and a top 10 holdings concentration of 52.85%. Maverick Capital Ltd's ...

About Lee AinslieLee Ainslie is the founder and CEO of Dallas-based Maverick Capital. Ainslie started Maverick Capital back in 1993 with $38 million after learning from legendary fund manager Julian Robertson at Tiger...

Company
Ticker
Market Value
% Portfolio
Shares
Change
Chg. Shares
Quarter End Price
Current Price
Yearly High
Yearly Low
Market Cap
% Owned
443.18M
6.76%
5.21M
337.42%
4.02M
$85.14
442.92M
6.76%
1.46M
New
1.46M
$303.46
418.35M
6.38%
363.35K
2.08%
7.39K
$1,151.37
ARMK
386.10M
5.89%
12.47M
12.13%
1.35M
$30.97
$37.93
$39.95
$28.74
9.78B
4.84%
COMM
355.17M
5.42%
11.64M
-0.15%
-18.01K
$30.51
$11.82
$14.61
$5.56
2.46B
5.59%
323.53M
4.94%
621.57K
-11.88%
-83.77K
$520.51
283.75M
4.33%
2.13M
-11.68%
-282.43K
$132.93
270.40M
4.13%
10.57M
-22.08%
-3.00M
$25.57
269.73M
4.12%
5.33M
85.53%
2.46M
$50.63
RDN
269.57M
4.11%
14.37M
-17.37%
-3.02M
$18.76
$20.82
$24.84
$17.97
3.36B
8.89%
TDG
247.24M
3.77%
1.10M
-18.38%
-247.83K
$224.67
$587.10
$686.06
$500.08
31.84B
2.03%
SABR
230.66M
3.52%
9.69M
38.38%
2.69M
$23.80
$6.87
$12.65
$5.45
2.20B
3.03%
218.67M
3.34%
2.40M
New
2.40M
$91.20
AER
205.92M
3.14%
4.50M
22.19%
816.55K
$45.79
$46.38
$71.38
$37.2
11.40B
1.83%
ADBE
188.46M
2.88%
2.33M
-32.68%
-1.13M
$81.01
$309.13
$699.54
$305
144.67B
0.50%
176.28M
2.69%
2.70M
-27.36%
-1.02M
$65.33
168.08M
2.57%
756.61K
-40.70%
-519.25K
$222.15
VMC
161.05M
2.46%
1.92M
-15.49%
-351.62K
$83.93
$162.22
$213.65
$137.54
21.56B
1.44%
BIDU
158.81M
2.42%
797.74K
-27.00%
-295.04K
$199.08
$127.31
$182.6
$101.62
44.70B
0.23%
155.22M
2.37%
9.76M
38.34%
2.71M
$15.90

Holdings Breakdown

Legend
Kraft Foods Group Inc
Allergan Plc
Priceline Grp Inc
ARMK
COMM
Google Inc
Avago Technologies Ltd
Santander Consumer Usa Hdg I
Liberty Global Plc
RDN
TDG
SABR
Kansas City Southern
AER
ADBE
Team Health Holdings Inc
Valeant Pharmaceuticals Intl
VMC
BIDU
Other
Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.